KIR2DL4 (CD158d): An activation receptor for HLA-G
Top Cited Papers
Open Access
- 1 January 2012
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 3, 258
- https://doi.org/10.3389/fimmu.2012.00258
Abstract
KIR2DL4 is an unusual KIR family member in terms of its structure, expression, cellular localization and signaling properties. The most conserved KIR in evolution, it is referred to as a framework KIR gene and is expressed by all natural killer cells and a subset of T cells. Although it has a long cytoplasmic tail that is typical of inhibitory KIR, engagement of this receptor results in the activation of NK cells, not for cytotoxicity, but for cytokine and chemokine secretion. Unlike all other KIRs, which are expressed on the surface of NK cells, KIR2DL4 resides in endosomes. It signals from this intracellular site for a proinflammatory and proangiogenic response, using a novel endosomal signaling pathway that involves the serine/threonine kinases DNA-PKcs and Akt. The only known ligand of KIR2DL4 is HLA-G. Soluble HLA-G accumulates in KIR2DL4+ endosomes. Unlike classical HLA molecules that serve as ligands for other KIR family members, in healthy individuals, HLA-G expression is restricted to the fetal trophoblast cells that invade the maternal decidua during early pregnancy. Since NK cells constitute the predominant lymphocyte subset at this site, the proinflammatory/proangiogenic outcome of the interaction between KIR2DL4 and soluble HLA-G supports a role for KIR2DL4 in the extensive remodeling of the maternal vasculature during the early weeks of pregnancy.Keywords
This publication has 37 references indexed in Scilit:
- Maternal KIR and fetal HLA-C: a fine balanceJournal of Leukocyte Biology, 2011
- Ubiquitylation of an Internalized Killer Cell Ig-Like Receptor by Triad3A Disrupts Sustained NF-κB SignalingThe Journal of Immunology, 2011
- Cutting Edge: Induction of IFN-γ Production but Not Cytotoxicity by the Killer Cell Ig-Like Receptor KIR2DL4 (CD158d) in Resting NK CellsThe Journal of Immunology, 2001
- HLA-G2, -G3, and -G4 Isoforms Expressed as Nonmature Cell Surface Glycoproteins Inhibit NK and Antigen-Specific CTL CytolysisThe Journal of Immunology, 2001
- HLA-G1 co-expression boosts the HLA class I-mediated NK lysis inhibitionInternational Immunology, 2001
- HLA class I recognition by killer cell Ig-like receptorsSeminars in Immunology, 2000
- Inhibitory receptors sensing HLA-G1 molecules in pregnancy: Decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptorProceedings of the National Academy of Sciences of the United States of America, 1999
- A Human Histocompatibility Leukocyte Antigen (HLA)-G–specific Receptor Expressed on All Natural Killer CellsThe Journal of Experimental Medicine, 1999
- Tetrameric Complexes of Human Histocompatibility Leukocyte Antigen (HLA)-G Bind to Peripheral Blood Myelomonocytic CellsThe Journal of Experimental Medicine, 1999
- Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysisProceedings of the National Academy of Sciences of the United States of America, 1997